About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 375 record(s)
Req # A-2023-03897
We read the article entitled "After pharma lobbying, minister intervened to suspend drug-price reform" published by the media "The Breach": https://breachmedia.ca/after-pharma-lobbying-minister-intervened-tosuspend-drug-price-reform/ We understand that someone from "The Breach" (its author Kelly Crowe or someone else) has requested information from the PMPRB to write the article. We cannot find this request through the archives of the Access to Information and Personal Information Online Request Service. We therefore request all communication, records and documents which were communicated in this request and/or relating to the information behind the aforementioned article which have been provided to The Breach or its employees.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2021-00031
All notes written or created during or after any facility inspections conducted in 2021; all photographs and video recordings created during any facility inspections conducted in 2021. This includes handwritten and digital notes.Organization: The Correctional Investigator Canada
March 2023
Req # A2022-0008
Please release all records related to the “reviews of the use of force incidents” referenced on page 200 of the release package from access to information request file A2021-00034. Omit duplicate records.Organization: The Correctional Investigator Canada
March 2023
Req # A-2022-00014
Records about Edmonton Institution heating and coolingOrganization: The Correctional Investigator Canada
March 2023
Nothing to report this month
Organization: The Correctional Investigator Canada
Req # A-2021-00016
All communications obtained by CSE from foreign and Canadian sources regarding Quebec referendum in 1995.Organization: Communications Security Establishment Canada
February 2023
Req # A-2022-00015
All situation reports from the Centre for Cyber Security related to the cyber incident in Newfoundland and Labrador from October 24 to November 30 2021.Organization: Communications Security Establishment Canada
February 2023
Req # A-2022-00028
Records describing the program/agenda for the November 2022 "Take Our Kids to Work Day" at CSE, including the location of activities, the identity and job of any CSE employees who made presentations, and the contents of those presentations.Organization: Communications Security Establishment Canada
February 2023
Req # A-2022-00030
Mission Policy Suite Standard Operational Procedure 4: Handling Privacy IncidentsOrganization: Communications Security Establishment Canada
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023